| Stage | COST | % of rev | AVGO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $95.7B | 100.00% | $29.6B | 100.00% | COST ×3.23 |
| Gross profit | $12.2B | 12.74% | $20.5B | 69.13% | AVGO +56.4pp |
| Operating income | $3.8B | 3.97% | $16.0B | 53.92% | AVGO +49.9pp |
| Pre-tax income | $4.0B | 4.19% | $15.3B | 51.62% | AVGO +47.4pp |
| Net income | $3.0B | 3.13% | $13.1B | 44.23% | AVGO +41.1pp |
| Stage | COST | AVGO | Gap · A − B |
|---|---|---|---|
| Revenue | $95.7B100.00% | $29.6B100.00% | COST ×3.23 |
| Gross profit | 12.74%$12.2B | 69.13%$20.5B | AVGO +56.4pp |
| Operating income | 3.97%$3.8B | 53.92%$16.0B | AVGO +49.9pp |
| Pre-tax income | 4.19%$4.0B | 51.62%$15.3B | AVGO +47.4pp |
| Net income |
| 3.13%$3.0B |
| 44.23%$13.1B |
| AVGO +41.1pp |
No shared counterparties.